We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for September 5th
Read MoreHide Full Article
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th:
The E.W. Scripps Company (SSP - Free Report) : This media enterprise has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 15.3% over the last 60 days.
Rexahn Pharmaceuticals, Inc. : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.5% over the last 60 days.
Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for September 5th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th:
The E.W. Scripps Company (SSP - Free Report) : This media enterprise has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 15.3% over the last 60 days.
E.W. Scripps Company (The) Price and Consensus
E.W. Scripps Company (The) price-consensus-chart | E.W. Scripps Company (The) Quote
E.W. Scripps’ shares gained 2.1% over the last one month more than S&P 500’s gain of 1.3%. The company possesses a Momentum Score of B.
E.W. Scripps Company (The) Price
E.W. Scripps Company (The) price | E.W. Scripps Company (The) Quote
Rexahn Pharmaceuticals, Inc. : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.5% over the last 60 days.
Rexahn Pharmaceuticals, Inc. Price and Consensus
Rexahn Pharmaceuticals, Inc. price-consensus-chart | Rexahn Pharmaceuticals, Inc. Quote
Rexahn’s shares gained 9.3% over the last one month. The company possesses a Momentum Score of A.
Rexahn Pharmaceuticals, Inc. Price
Rexahn Pharmaceuticals, Inc. price | Rexahn Pharmaceuticals, Inc. Quote
Interface, Inc. (TILE - Free Report) : This modular flooring company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.
Interface, Inc. Price and Consensus
Interface, Inc. price-consensus-chart | Interface, Inc. Quote
Interface’s shares gained 6.4% over the last one month. The company possesses a Momentum Score of B.
Interface, Inc. Price
Interface, Inc. price | Interface, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>